A total hip replacement infected with mycobacterium bovis after intravesicular treatment with Bacille-Calmette-Guérin for bladder cancer

Journal of Bone and Joint Surgery - Series B

Volumn 90, Issue 2, 2008, Pages 225-227

  Reigstad, O ^a,b   Siewers, P ^a,c  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c MARTINA HANSENS HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; EPIRUBICIN; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

AGED; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BLADDER CANCER; CANCER PATIENT; CASE REPORT; CLINICAL STUDY; FOLLOW UP; HARRIS HIP SCORE; HUMAN; HUMAN TISSUE; IMPLANTATION; MALE; MYCOBACTERIUM BOVIS; OSTEOARTHRITIS; PRIORITY JOURNAL; PROSTHESIS LOOSENING; PUS; RADIOLOGY; TOTAL HIP PROSTHESIS; TUBERCULOSIS;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRAVESICAL; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, HIP; BCG VACCINE; COMBINED MODALITY THERAPY; HUMANS; MALE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM INFECTIONS; PROSTHESIS FAILURE; PROSTHESIS-RELATED INFECTIONS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 39749138123     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620X.90B2.20038     Document Type: Article

References (12)

1. Perdreau-Remington F, Stefanik D, Peters G, et al. A four-year prospective study on microbial ecology of explanted prosthetic hips in 52 patients with "aseptic" prosthetic joint loosening. Eur J Clin Microbial Infect Dis 1996;15:160-5.
2. WHO. Fact sheet No. 104 Tuberculosis. 2006. http://www.who.int/ mediacentre/factsheets/fs104/en (date accessed 12 December 2007).
3. Harris WH. Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty: an end-result study using a new method of result evaluation. J Bone Joint Surg [Am] 1969;51-A:737-55.
4. Guérin C. The history of BCG. In: Rosenthal SR, ed. BCG vaccine: tuberculosis-cancer PSG: Littleton, 1980:35-43.
5. Morales A, Eidinger D, Bruce AW. Intracavitary bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J Urol 1976;116:180-3.
6. Martínez-Pineiro JA, Martínez-Pineiro L. BCG update: intravesical therapy. Eur Urol 1997;31(Suppl 1):31-41.
7. Witjes JA. Bladder carcinoma in situ in 2003: state of the art. Eur Urol 2004;45:142-6.
8. Gonzalez OY, Musher DM. Brar I, et al. Spectrum of bacille Calmett-Guerin (BCG) infection after intravesical BCG immunotherapy. Clin Infect Dis 2003;36:140-8.
9. Guerra CE, Betts RF, O'Keefe RJ, Shilling JW. Mycobacterium bovis osteomyelitis involving a hip arthroplasty after intravesicular bacille Calmette-Guerin for bladder cancer. Clin Infect Dis 1998;27:639-40.
10. Marmor M, Parnes N, Dekel S. Tuberculosis infection complicating total knee arthroplasty: report of 3 cases and review of the literature. J Arthroplasty 2004;19:397-400.
11. Ha KY, Chung YG, Ryoo SJ. Adherence and biofilm formation of Staphylococcus epidermidis and Mycobacterium tuberculosis on various spinal implants. Spine 2005;30:38-43.
12. Frieden TR, Sterling TR, Munsiff SS, Watt CJ, Dye C. Tuberculosis. Lancet 2003;362:887-99.